regeneron glp-1 gip treatment muscle loss side effects Pharmaceuticals announced on January 30, 2026, that its experimental obesity drug candidate delivers significant cholesterol-lowering benefits on top of weight loss—a differentiation strategy aimed at competing with Eli Lilly's and Novo Mitigating loss of lean muscle

Researchers became interested when early trials demonstrated unprecedented efficacy in metabolic controlwith some studies showing nearly 30% of subjects achieving normoglycemia and over 20% average weight losseffects that suggested the dual incretin approach might unlock mechanisms beyond what single-target agonists could achieve

It took Knudsen three years to determine why this happened

One of the most important things individuals can do to help quiet food noise is to begin incorporating practices of mindful and intuitive eating, which in turn aids in the learning and awareness of hunger and fullness cues, explains Bakovic

doi:10.1210/clinem/dgz047 AdipoGen Life Science